CJC-1295 with DAC 5mg

CJC-1295 with DAC is a modified growth-hormone-releasing hormone (GHRH) analogue. GHRH is a signalling hormone involved in pituitary growth-hormone release.

DAC is an albumin-binding attachment designed to keep the analogue in circulation longer. Published experiments have examined its receptor activity and albumin binding. It is chemically different from the product sold as CJC No DAC.

Sources: GHRH analogue and DAC study

One vial labelled 5mg of CJC-1295 with DAC, supplied as lyophilised (freeze-dried) powder. The mg value is the labelled amount in the vial, not a solution concentration.

For Research Use Only, for in vitro laboratory work. Not for human or animal consumption.

No source report is linked to this strength as its current batch. Contact Pillar Research for the matching report before ordering if it is required for your work.

Pillar Research lists CJC-1295 with DAC 5mg on this product page for Research Use Only. This strength is available to add to cart. In-stock orders ship from Australia; see the shipping information at checkout for the dispatch estimate and delivery options.

Orders are placed online. For in-stock items, select the quantity and add to cart; for preorders, check the dispatch estimate before ordering.

CJC-1295 with DAC 5mg is listed at A$99.99 per vial, in Australian dollars. The price is for this strength, not every variant.

Any applicable offer and shipping charges are shown in the order total before payment. Check the availability shown above before ordering.

Follow the storage conditions and expiry on the supplied label and any accompanying handling documentation. Keep the original container and batch identification.

If a temperature range or shelf life is missing, request it before use. A general product-page answer cannot establish stability after a laboratory preparation is made.